110 related articles for article (PubMed ID: 12150052)
21. No adverse events after simultaneous administration of 50 000 IU vitamin A and Bacille Calmette-Guerin vaccination to normal-birth-weight newborns in Guinea-Bissau.
Nante JE; Diness BR; Ravn H; Roth A; Aaby P; Benn CS
Eur J Clin Nutr; 2008 Jul; 62(7):842-8. PubMed ID: 17538544
[TBL] [Abstract][Full Text] [Related]
22. Comparison of adverse effects following immunization with vaccine containing whole-cell vs. acellular pertussis components.
Zieliński A; Rosińska M
Przegl Epidemiol; 2008; 62(3):589-96. PubMed ID: 19108523
[TBL] [Abstract][Full Text] [Related]
23. [Vaccine prophylaxis of tuberculosis: implication and problems].
Aksenova VA; Levi DT; Fonina EV; Vundtsettel' NN
Probl Tuberk Bolezn Legk; 2009; (1):10-6. PubMed ID: 19253677
[TBL] [Abstract][Full Text] [Related]
24. [Recent problem of skin lesions induced by BCG vaccination].
Mori T; Yamauchi Y
Kekkaku; 2009 Mar; 84(3):109-15. PubMed ID: 19364042
[TBL] [Abstract][Full Text] [Related]
25. Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety.
Chen JM; Islam ST; Ren H; Liu J
Vaccine; 2007 Nov; 25(48):8114-22. PubMed ID: 17954004
[TBL] [Abstract][Full Text] [Related]
26. The influence of BCG immunisation on tuberculin reactivity and booster effect in adults in a country with a high prevalence of tuberculosis.
Hizel K; Maral I; Karakus R; Aktas F
Clin Microbiol Infect; 2004 Nov; 10(11):980-3. PubMed ID: 15522000
[TBL] [Abstract][Full Text] [Related]
27. Primary inoculation tuberculosis after immunotherapy for malignant melanoma with BCG vaccine.
Caplan SE; Kauffman CL
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):783-5. PubMed ID: 8912582
[No Abstract] [Full Text] [Related]
28. [BCG vaccine administration schedule and primary immunodeficiencies: Is it time for a change?].
Sotomayor F C; Palma B J
Rev Chil Pediatr; 2019 Dec; 90(6):668-674. PubMed ID: 32186591
[TBL] [Abstract][Full Text] [Related]
29. Chapter 5: Health staff roles and responsibilities, recording and reporting and BCG vaccination.
;
Int J Tuberc Lung Dis; 2007 Feb; 11(2):134-7. PubMed ID: 17263281
[TBL] [Abstract][Full Text] [Related]
30. [Surveillance of the safety of intravesical BCG therapy in France: quantitative analysis of serious adverse events notified over a period of five years].
Debois H; Loupi E; Saliou P
Prog Urol; 2002 Sep; 12(4):604-8. PubMed ID: 12463118
[TBL] [Abstract][Full Text] [Related]
31. [Adverse events following BCG vaccination in infants and children up to 36 months of age].
Gołebiowska M; Andrzejewska E; Stryjewska I; Baranowska H; Drazkiewicz A
Przegl Epidemiol; 2008; 62(1):71-5. PubMed ID: 18536227
[TBL] [Abstract][Full Text] [Related]
32. Adverse effects of BCG revaccination: a report on 13 cases from Rio de Janeiro, Brazil.
Cunha AJ; Sant'Anna CC; Mannarino R; Labanca TC; Ferreira S; March MF
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1110-3. PubMed ID: 12546120
[TBL] [Abstract][Full Text] [Related]
33. Lupus vulgaris at the site of BCG vaccination: report of three cases.
Farsinejad K; Daneshpazhooh M; Sairafi H; Barzegar M; Mortazavizadeh M
Clin Exp Dermatol; 2009 Jul; 34(5):e167-9. PubMed ID: 19094126
[TBL] [Abstract][Full Text] [Related]
34. New vaccines against tuberculosis: lessons learned from BCG immunisation in Brazil.
Antas PR; Castello-Branco LR
Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):628-30. PubMed ID: 18440575
[TBL] [Abstract][Full Text] [Related]
35. [The use of factorial correlation-regression analysis in the evaluation of the efficiency of BCG immunization in children].
Aksiutina LP
Probl Tuberk Bolezn Legk; 2006; (3):35-7. PubMed ID: 16817557
[TBL] [Abstract][Full Text] [Related]
36. Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis.
Haile M; Schröder U; Hamasur B; Pawlowski A; Jaxmar T; Källenius G; Svenson SB
Vaccine; 2004 Mar; 22(11-12):1498-508. PubMed ID: 15063575
[TBL] [Abstract][Full Text] [Related]
37. [Tuberculosis in Poland, Europe, and world. Part I--prevalence].
Zielonka TM
Pol Merkur Lekarski; 2006 Sep; 21(123):243-52. PubMed ID: 17163186
[TBL] [Abstract][Full Text] [Related]
38. Adverse effects of BCG vaccination; mainly BCG infection.
Prescrire Int; 2003 Dec; 12(68):220-4. PubMed ID: 14986693
[TBL] [Abstract][Full Text] [Related]
39. BCG vaccine-associated suppurative lymphadenitis.
Teo SS; Smeulders N; Shingadia DV
Vaccine; 2005 Apr; 23(20):2676-9. PubMed ID: 15780451
[TBL] [Abstract][Full Text] [Related]
40. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
